News related to Symbyax (Olanzapine / Fluoxetine) and/or conditions it is approved for
Schizophrenia And Bipolar Disorder - Clinical Feasibility Of Once-a-Day Ziprasidone
Source: Bipolar News From Medical News Today [2008.11.13]
Lipocine Inc., a specialty pharmaceutical company that uses clinically validated proprietary technologies to address key unmet drug delivery and therapeutic needs, today announced the successful completion of a clinical study that establishes feasibility of the first once-a-day dosing product for Ziprasidone, a leading treatment for schizophrenia and bipolar disorder. - Schizophrenia affects 1% of the population and bipolar disorder affects 5.7M adults in the US*.
SEROQUEL XR™ And SEROQUEL(R) Approved In Europe For New Indications For The Treatment Of Bipolar Disorder
Source: Bipolar News From Medical News Today [2008.11.13]
AstraZeneca today announced that the once-daily formulation SEROQUEL XR™ (quetiapine fumarate extended release tablets) and SEROQUEL® (quetiapine fumarate) have been approved via the Mutual Recognition Procedure for new indications in bipolar disorder. SEROQUEL XR and SEROQUEL have been approved for treatment of major depressive episodes in bipolar disorder. Additionally, SEROQUEL XR has been approved for treatment of moderate to severe manic episodes in bipolar disorder.
Repligen Initiates Phase 2b Clinical Trial Of RG2417 In Bipolar Disorder
Source: Bipolar News From Medical News Today [2008.11.07]
Repligen Corporation (Nasdaq: RGEN) announced that the Company has initiated a Phase 2b clinical trial to evaluate the use of RG2417, an oral formulation of uridine, in patients with bipolar depression. This Phase 2b study is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or placebo twice daily for eight weeks.
Health Tip: Managing Bipolar Disorder
Source: MedicineNet Bipolar Disorder Specialty [2008.11.06]
Title: Health Tip: Managing Bipolar Disorder
Category: Health News
Created: 11/6/2008 2:00:00 AM
Last Editorial Review: 11/6/2008
Bipolar Disorder Involves A Lower Quality Of Both Mental And Physical Life, Even In Periods Of Normality
Source: Bipolar News From Medical News Today [2008.10.31]
A study carried out in the Institute of Neurosciences of the University of Granada (Spain) and the Mental Health Unit of the Hospital Neurotraumatológico of Jaen (Spain) has evaluated the quality of life of patients suffering from bipolar disorder (BD), in comparison with the general population, and which variables are connected with patients with a lower quality of life.
Both Mental And Physical Quality Of Life Affected By Bipolar Disorder
Source: Bipolar News From Medical News Today [2008.10.29]
This press release is available in French and Spanish.
Patient Groups Tackle Stigma Attached To Bipolar Disorder And Other Mental Illnesses With New Tools
Source: Bipolar News From Medical News Today [2008.10.23]
Mental illness is one of the last surviving stigmas in today's liberal society. Class, race, religion, gender and sexual orientation, are all off-limits now as reasons for discrimination, social exclusion, jokes or disparaging remarks of any kind. Where these are concerned, we've come a long way in terms of tolerance, fairness and sensitivity to the feelings of others; as a rule, words are chosen carefully so as not to offend and legislation ensures fair treatment.
Childhood Bipolar Disorder Could Extend Into Young Adulthood
Source: Bipolar News From Medical News Today [2008.10.07]
Young adults who had bipolar disorder as children are likely to suffer from manic episodes, according to an article released on October 6, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. Bipolar disorder is a severe mood disorder that involves episodes of mania and depression. There is significant debate about how pediatric bipolar disorder, which affects children, should be diagnosed.
Common Gene Mutation Lowers Risk for Bipolar Disorder
Source: MedicineNet Bipolar Disorder Specialty [2008.09.30]
Title: Common Gene Mutation Lowers Risk for Bipolar Disorder
Category: Health News
Created: 9/30/2008 2:00:00 AM
Last Editorial Review: 9/30/2008
52 Percent Of Newly Diagnosed Bipolar Disorder Patients Receive Antidepressant Drugs In First-Line Treatment
Source: Bipolar News From Medical News Today [2008.09.16]
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that 52.3 percent of newly diagnosed bipolar disorder patients are prescribed antidepressant drugs first line. The new report entitled Treatment Algorithms in Bipolar Disorder finds that this high preponderance of early-line antidepressant use stems from primary care physician prescribing.
New Data Highlight Benefit Of SEROQUEL Monotherapy For Long-Term Treatment Of Bipolar Disorder
Source: Bipolar News From Medical News Today [2008.09.03]
Results presented at the 21st European College of Neuropsychopharmacology (ECNP) congress in Barcelona, Spain have demonstrated the efficacy of SEROQUEL® (quetiapine fumarate) monotherapy for maintenance treatment in patients with bipolar disorder.
FDA Approves First Generic Divalproex Sodium To Treat Seizures, Migraine Headaches And Bipolar Disorder
Source: Headache / Migraine News From Medical News Today [2008.08.01]
The U.S. Food and Drug Administration approved the first generic versions of Depakote delayed-release tablets (divalproex sodium). Depakote is approved by the FDA for the treatment of seizures, bipolar disorder and migraine headaches. "Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," said Gary J.
Breast Cancer Drug Might Treat Bipolar Disorder
Source: MedicineNet lorazepam Specialty [2008.03.04]
Title: Breast Cancer Drug Might Treat Bipolar Disorder
Category: Health News
Created: 3/4/2008 2:00:00 AM
Last Editorial Review: 3/4/2008
Abilify Approved for Children With Bipolar Disorder
Source: MedicineNet aripiprazole Specialty [2008.03.03]
Title: Abilify Approved for Children With Bipolar Disorder
Category: Health News
Created: 3/1/2008 2:00:00 AM
Last Editorial Review: 3/3/2008
Bipolar Disorder (Mania)
Source: MedicineNet aripiprazole Specialty [2007.10.01]
Title: Bipolar Disorder (Mania)
Category: Diseases and Conditions
Created: 1/13/2003
Last Editorial Review: 10/1/2007
Awareness Campaign - To Dispel Myths About Mood Disorders - Mood Disorders Association Of Ontario
Source: Bipolar News From Medical News Today [2008.10.08]
The Mood Disorders Association of Ontario (MDAO) today launches "It's All In Your Head!" an initiative to promote awareness of the work of the MDAO and dispel myths about mental illness. Volunteers will be in the Yonge-Eglinton subway station and the Yonge-Eglinton Centre to hand out "heady" information to commuters during the evening rush hour. Mood disorders, such as depression and bipolar disorder will affect one in five individuals at some point in their life.
Global Psychiatrists Unite To Improve Services In Mental Health
Source: Bipolar News From Medical News Today [2008.09.19]
Thirty seven medical experts in psychiatry from across the world have called on the medical community to take urgent action to optimize services for people with a diagnosis of severe mental illness such as schizophrenia or bipolar disorder(i). Professor W.
AstraZeneca's Seroquel XL, Once Daily Formula, Now Available For UK Patients
Source: Bipolar News From Medical News Today [2008.09.18]
Seroquel XL (quetiapine prolonged release) a new, once daily formulation for schizophrenia and manic episodes associated with bipolar disorder, has today become available in the UK.[1] The new formulation was developed to address the needs of patients who require effective control of symptoms in a once daily rather than twice daily tablet.
Seroquel XL (Quetiapine Prolonged Release): A Once Daily Formulation For Bipolar Mania And Schizophrenia Launches Today, UK
Source: Bipolar News From Medical News Today [2008.09.15]
Today, Seroquel XL (quetiapine prolonged release), a new once daily formulation for schizophrenia and manic episodes associated with bipolar disorder, has become available in the UK.1 AstraZeneca has developed the new formulation of its atypical antipsychotic treatment to meet the needs of patients for whom a once daily dose is preferred and/or for whom1 effective control of symptoms is important.
Family Therapy With Medication Improves Depression In Bipolar Teens
Source: Bipolar News From Medical News Today [2008.09.05]
In combination with medication, family-focused therapy appears to help curb depression symptoms in teens with bipolar disorder, according to a report released on September 1, 2008 in the Archives of General Psychiatry, one of the JAMA/Archives journals. Bipolar disorders are characterized by occasional periods of elevated mood, known as mania.
Healthy Minds Across America Features 48 Public Forums On Mental Health Research, Sept. 14
Source: Bipolar News From Medical News Today [2008.09.04]
People concerned about the toll that mental health disorders are taking on their families and communities will have a unique opportunity to hear from world-class experts on what is known to-date about the causes, symptoms and progression of such illnesses as depression, bipolar disorder, anxiety, schizophrenia and autism, and learn about current and potential treatments.
|
